 |
|
Anesthesia and Alzheimer's
April 28, 2008In studies of human brain cells, the widely-used anesthetic desflurane does not contribute to increased production of amyloid-beta protein; however, when combined with low oxygen conditions, it can produce more of this Alzheimer's associated protein.
Over 200 million people undergo surgery each year, and there has been concern that anesthetic use may contribute to Alzheimer's and other brain disorders. Bin Zhang, Yuanlin Dong, Rudolph Tanzi, Zhongcong Xie, and colleagues examined this possibility with commonly used inhalation anesthetics isoflurane previously and desflurane more recently.
They subjected human brain cells to 12% desflurane for six hours (mimicking a surgery condition) and observed no changes in either the production of amyloid-beta protein or the rate of cell death. However, when combined with low oxygen levels (18%), desflurane could stimulate these cellular changes associated with Alzheimer's (hypoxia by itself did not induce any changes). The results with desflurane are contrary to the researchers' previous work, which found isoflurane by itself could stimulate both amyloid production and cell death.
The researchers do emphasize that the current findings are from cell culture experiments, and the next critical step will be to confirm these findings in animal models and test the effects of other anesthetic agents. But, these early results suggest that it is important to ensure anesthetic patients maintain sufficient oxygen in their brain.
American Society for Biochemistry and Molecular Biology
The researchers do emphasize that the current findings are from cell culture experiments, and the next critical step will be to confirm these findings in animal models and test the effects of other anesthetic agents. But, these early results suggest that it is important to ensure anesthetic patients maintain sufficient oxygen in their brain.
American Society for Biochemistry and Molecular Biology
Amyloid-beta Current Events and Amyloid-beta News RSSHybrid molecules show promise for exploring, treating Alzheimer's
One of the many mysteries of Alzheimer's disease is how protein-like snippets called amyloid-beta peptides, which clump together to form plaques in the brain, may cause cell death, leading to the disease's devastating symptoms of memory loss and other mental difficulties.
Rethinking Alzheimer's disease and its treatment targets
The standard explanation for what causes Alzheimer's is known as the amyloid hypothesis, which posits that the disease results from of an accumulation of the peptide amyloid beta, the toxic protein fragments that deposit in the brain and become the sticky plaques that have defined Alzheimer's for more than 100 years.
Connections between diabetes and Alzheimer's disease explored
Modern societies face the increasing burden of age-related diseases, in particular Alzheimer's disease (AD) and type 2 diabetes (T2D).
Alzheimer's: New findings resolve long dispute about how the disease might kill brain cells
For a decade, Alzheimer's disease researchers have been entrenched in debate about one of the mechanisms believed to be responsible for brain cell death and memory loss in the illness.
Collagen VI may help protect the brain against Alzheimer's disease
Scientists from the Gladstone Institute of Neurological Disease (GIND), UCSF, and Stanford have discovered that a certain type of collagen, collagen VI, protects brain cells against amyloid-beta (Aβ) proteins, which are widely thought to cause Alzheimer's disease (AD).
A special type of collagen may help protect the brain against Alzheimer's disease
Scientists from the Gladstone Institute of Neurological Disease (GIND), UCSF, and Stanford have discovered that a certain type of collagen, collagen VI, protects brain cells against amyloid-beta (Aβ ) proteins, which are widely thought to cause Alzheimer's disease (AD).
A high-fat diet could promote the development of Alzheimer's
A team of Université Laval researchers has shown that the main neurological markers for Alzheimer's disease are exacerbated in the brains of mice fed a diet rich in animal fat and poor in omega-3s.
Alzheimer's disease patients show improvement in trial of new drug
A new drug has been shown to improve the brain function of people with early stage Alzheimer's disease and reduce a key protein associated with the disease in the spinal fluid, in a small study published today in the journal Lancet Neurology and presented at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease.
The good and the bad of a potential Alzheimer's target
Research in fruit flies has shown that enhancing the production of a protein called neprilysin can reduce the formation of plaques and neuron death associated with Alzheimer's, at the expense of reducing the flies' lifespan.
Vaccine triggers immune response, prevents Alzheimer's
A vaccine created by University of Rochester Medical Center scientists prevents the development of Alzheimer's disease-like pathology in mice without causing inflammation or significant side effects.
More Amyloid-beta Current Events and Amyloid-beta News Articles
 |
Alzheimer's Disease: Cellular and Molecular Aspects of Amyloid beta (Subcellular Biochemistry) by Robin Harris (Editor), Falk Fahrenholz (Editor) Preface: To understand Alzheimer?s disease (AD) is one of the major thrusts of present-day clinical research, strongly supported by more fundamental cellular, biochemical, immunological and structural studies. It is these latter that receive attention within this book. This compilation of 20 chapters indicates the diversity of work currently in progress and summarizes the current state of knowledge. Experienced authors who are scientifically active in their fields of study have been selected as contributors to this book, in an attempt to present a reasonably complete survey of the field. Inevitably, some exciting topics for one reason or another have not been included, for which we can only apologize. Standardization of terminology is often a problem in science, not least... |
![[beta]-amyloid Peptide (1-42), Human, Oncogene - Size 250 Ug - Model Pp69--25mg - Each (.25 Mg)](http://ecx.images-amazon.com/images/I/31Y1NF0J0EL._SL160_.gif) |
[beta]-amyloid Peptide (1-42), Human, Oncogene - Size 250 Ug - Model Pp69--25mg - Each (.25 Mg) by Oncogene [beta]-Amyloid Peptide (1-42), Human, Oncogene - Size 250 ug - Model PP69--25MG - Each (.25 MG) : Lyophilized.Synthetic peptide corresponding to amino acids 1-42 of the processed human amyloid peptide. Supplied in a form that is not neurotoxic prior to preincubation. The level of toxicity has recently been shown to correlate to the extent of beta sheet structure. Reconstitute with degassed HPLC grade deionized water. Purity: >95% by HPLC. FW: 4 kDa. |
|
Nerve link: Alzheimer's suspect shows up in glaucoma.(This Week)(amyloid beta-protein): An article from: Science News by N. Seppa (Author) This digital document is an article from Science News, published by Thomson Gale on August 11, 2007. The length of the article is 483 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Nerve link: Alzheimer's suspect shows up in glaucoma.(This Week)(amyloid beta-protein) Author: N. Seppa Publication: Science News (Magazine/Journal) Date: August 11, 2007 Publisher: Thomson Gale Volume: 172 Issue: 6 Page: 84(2) Distributed by Thomson... | |
 |
Amyloid Proteins: The Beta Sheet Conformation and Disease by Jean D. Sipe (Editor) A first-stop reference on proteins associated with amyloidosis. This book is the first to present a systematic overview of all known fibril-forming proteins, including their biochemical characteristics and pathophysiology. It considers the clinically recognized amyloid proteins that are known to be associated with the amyloid protein folding disorders, dealing with their common structural and thermodynamic features that lead to amyloid fibril formation and disease. Emphasis is on the thermodynamics of protein folding, the structure and physiologic effects of common oligomeric and subfibrillar intermediates and the influence of the extracellular matrix and cellular trafficking and metabolism on the genesis and catabolism of beta pleated sheet proteins. The chapters on... |
|
PET scans show [beta]-Amyloid, promise early Alzheimer's Dx. (Very Preliminary Data).: An article from: Family Practice News by Miriam E. Tucker (Author) This digital document is an article from Family Practice News, published by International Medical News Group on September 15, 2002. The length of the article is 468 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: PET scans show [beta]-Amyloid, promise early Alzheimer's Dx. (Very Preliminary Data). Author: Miriam E. Tucker Publication: Family Practice News (Magazine/Journal) Date: September 15, 2002 Publisher: International Medical News Group Volume: 32 Issue: 18 Page: 2(1) Distributed by Thomson... | |
|
Beta amyloid: the peptide that kills from both the outside and inside to produce Alzheimer's disease. (Collegiate Communications--Undergraduate).(Brief ... of the North Dakota Academy of Science by Jason Spah (Author), Katherine Splichal (Author), Kali Wilson (Author), Garl K. Rieke (Author) This digital document is an article from Proceedings of the North Dakota Academy of Science, published by North Dakota Academy of Science on April 1, 2000. The length of the article is 897 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Beta amyloid: the peptide that kills from both the outside and inside to produce Alzheimer's disease. (Collegiate Communications--Undergraduate).(Brief Article) Author: Jason Spah Publication: Proceedings of the North Dakota Academy of Science (Refereed) Date: April 1, 2000 Publisher: North Dakota Academy of Science Page:... | |
|
Brain sabotage: Alzheimer's protein may spawn miniseizures.(This Week)(Amyloid beta-protein): An article from: Science News by N. Seppa (Author) This digital document is an article from Science News, published by Thomson Gale on September 15, 2007. The length of the article is 536 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Brain sabotage: Alzheimer's protein may spawn miniseizures.(This Week)(Amyloid beta-protein) Author: N. Seppa Publication: Science News (Magazine/Journal) Date: September 15, 2007 Publisher: Thomson Gale Volume: 172 Issue: 11 Page: 165(2) Distributed by Thomson... | |
|
Genetic variant tied to amyloid-[beta] generation in Alzheimer's.(Geriatric Psychiatry)(Clinical report): An article from: Clinical Psychiatry News by Jeff Evans (Author) This digital document is an article from Clinical Psychiatry News, published by Thomson Gale on April 1, 2007. The length of the article is 763 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Genetic variant tied to amyloid-[beta] generation in Alzheimer's.(Geriatric Psychiatry)(Clinical report) Author: Jeff Evans Publication: Clinical Psychiatry News (Magazine/Journal) Date: April 1, 2007 Publisher: Thomson Gale Volume: 35 Issue: 4 Page: 25(1) Article Type: Clinical report Distributed by Thomson... | |
|
Low plasma [beta]-amyloid levels may be a marker for cognitive decline.(Geriatric Psychiatry): An article from: Clinical Psychiatry News by Kerri Wachter (Author) This digital document is an article from Clinical Psychiatry News, published by Thomson Gale on October 1, 2005. The length of the article is 595 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Low plasma [beta]-amyloid levels may be a marker for cognitive decline.(Geriatric Psychiatry) Author: Kerri Wachter Publication: Clinical Psychiatry News (Magazine/Journal) Date: October 1, 2005 Publisher: Thomson Gale Volume: 33 Issue: 10 Page: 48(1) Distributed by Thomson... | |
|
FDG-PET scan targets [beta]-amyloid deposits. (May Predict Alzheimer's).: An article from: Internal Medicine News by Miriam E. Tucker (Author) This digital document is an article from Internal Medicine News, published by International Medical News Group on September 1, 2002. The length of the article is 485 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: FDG-PET scan targets [beta]-amyloid deposits. (May Predict Alzheimer's). Author: Miriam E. Tucker Publication: Internal Medicine News (Magazine/Journal) Date: September 1, 2002 Publisher: International Medical News Group Volume: 35 Issue: 17 Page: 4(1) Distributed by Thomson... |
| © 2009 BrightSurf.com |